✦ The News Desk
The full firehose — every desk, every dispatch, in chronological order. Last filed 13h ago.
If the BosSTENT pivotal trial succeeds, it could establish the first purpose-built interventional device for venous sinus stenosis–related pulsatile tinnitus, expanding the treatment pathway beyond audiology into neurovascular care.
✦ Search
✦ Filter